List Alan 4
4 · PRECISION BIOSCIENCES INC · Filed Jan 23, 2024
Insider Transaction Report
Form 4
List Alan
Chief Medical Officer
Transactions
- Sale
Common Stock
2024-01-22$0.36/sh−21,526$7,749→ 94,982 total - Exercise/Conversion
Restricted Stock Units
2024-01-20−60,012→ 119,988 total→ Common Stock (60,012 underlying) - Exercise/Conversion
Common Stock
2024-01-20+60,012→ 116,508 total
Footnotes (4)
- [F1]Represents the partial vesting and settlement of Restricted Stock Units ("RSUs") on January 20, 2024.
- [F2]Each RSU represents a contingent right to receive one share of the Issuer's Common Stock or, at the Issuer's option, an amount of cash equal to the fair market value of such share.
- [F3]The sales were effected pursuant to a Rule 10b5-1 plan adopted on September 10, 2021. The transaction was a sell-to-cover, with shares only sold to cover tax withholding obligations in connection with the vesting and settlement of RSUs. The Reporting Person did not sell or otherwise dispose of shares reported on this Form 4 for any reason other than to cover required taxes and fees.
- [F4]On January 20, 2023 the Reporting Person was granted RSUs, which vest in three substantially equal annual installments beginning on January 20, 2024, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates.